<DOC>
	<DOCNO>NCT00251316</DOCNO>
	<brief_summary>This study examine safety effectiveness use lithium , use enhance effectiveness high-dose 131I , single low dose ( 30 mCi ) 131I thyroid ablation patient recently diagnose papillary follicular thyroid cancer thyroid gland remove whose cancer spread beyond thyroid . Participants randomly assign receive lithium capsule placebo ( look-alike capsule active ingredient ) . They follow low-iodine diet 2 week start treatment admit NIH Clinical Center study treatment 11 day , remain low-iodine diet . Blood sample collect almost every day analyze thyroid hormone , kidney liver function , lithium concentration test .</brief_summary>
	<brief_title>Effect Lithium Carbonate Low-Dose Radioiodine Therapy Early Thyroid Cancer</brief_title>
	<detailed_description>Postsurgical thyroid remnant ablation ( 131 ) I consider standard clinical care case papillary follicular thyroid cancer , eliminate normal thyroid tissue may contain microscopic cancer . Furthermore , ablation enhances sensitivity subsequent ( 131 ) I scan serum thyroglobulin ( TG ) measurement detection recurrent persistent disease . Low dose ( 131 ) I ( 30 mCi ) successfully ablate thyroid remnant 8-61 % case . This dose repeat result overall less radiation exposure associate high dose therapy ( 100 mCi ) . Ablation achieve one small dose radioactive iodine associate decreased survival cancer recurrence . According literature difference 30-year recurrence rate group receive low high dose ablation therapy well differentiate thyroid cancer without distant metastasis time initial therapy . The benefit use low dose ( 131 ) I minimization whole body radiation exposure , reduction side effect low cost . Higher rate successful ablation low dose 131I could achieve increase uptake ( 131 ) I and/or lengthen retention radioiodine remnant thyroid tissue . Recombinant human thyroid-stimulating hormone ( rhTSH ) use successfully increase radioiodine uptake . Lithium used increase radioiodine retention show useful treatment residual metastatic cancer . The combination rhTSH lithium adjuncts 30 mCi radioactive iodine ( RAI ) ablation therapy low risk thyroid cancer patient may provide method reduces cumulative dose radioiodine need successfully treat thyroid cancer . The specific aim study determine whether adjunct lithium carbonate improve success rate postsurgical ablation thyroid remnant use low dose ( 131 ) I ( 30 mCi ) rhTSH low risk patient differentiate thyroid carcinoma . Patients well-differentiated papillary follicular thyroid cancer stage I II , accord National Thyroid Cancer Treatment Cooperative Study ( NTCTCS ) classification time surgery , enrol . Eligible patient total near-total thyroidectomy within 6 month enrollment . This randomized , placebocontrolled , double-blind study permit evaluation risk/benefit ratio add lithium adjuvant already establish method administer low-dose ( 131 ) I ablation therapy , optimize ( 131 ) I retention . All patient undergo diagnostic rhTSH ( 123 ) I whole body scan end study assess success thyroid ablation .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Patients older 16 year welldifferentiated papillary follicular thyroid cancer stage I II , accord NTCTCS classification time surgery 2 . Patients young 45 year size primary papillary follicular tumor 3 . Patients older 45 year : 1. primary papillary tumor le 4 cm 2. primary follicular tumor le 1 cm EXCLUSION CRITERIA 1 . Patients postsurgical thyroid remnant 5 g 2 . Patients distant metastasis 3 . Patients 45 year age : 1. known cervical lymph node metastases 2. microscopic multifocal follicular cancer 3. microscopic extraglandular invasion follicular cancer 4. gross extraglandular invasion papillary follicular cancer 4 . Patients confirm histological subtypes welldifferentiated thyroid cancer Hurtle cell carcinoma , insular tall cell variant papillary cancer . 5 . Pregnant lactate woman 6 . Patients renal impairment define repeat serum creatinine concentration 1.5 mg/dl thyroid hormone 7 . Patients chronic lithium therapy psychiatric illness 8 . Patients current unstable cardiovascular condition 9 . Patients severe chronic medical condition ( liver failure , severe debilitation , dehydration , sodium depletion , cancer require therapy , etc )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Thyroid Neoplasm</keyword>
	<keyword>I-131</keyword>
	<keyword>Radiation Dose</keyword>
	<keyword>Radiation Effect</keyword>
	<keyword>Pharmaceutical Adjuvant</keyword>
	<keyword>Thyroid Cancer</keyword>
</DOC>